LYRA - Wall Street Estimates - Lyra Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.214

5.52 %

$ 14 M

Market Cap

-0.14

P/E

Price Target Average

133.64%

Revenue Forecast Estimate

261.49%

EBIT Estimate

39.70%

Net Income Estimate

44.09%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Lyra Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for LYRA of $0.5 , with forecasts ranging from a low of $0.5 to a high of $0.5 .

LYRA Lowest Price Target Wall Street Target

0.5 USD 133.64%

LYRA Average Price Target Wall Street Target

0.5 USD 133.64%

LYRA Highest Price Target Wall Street Target

0.5 USD 133.64%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free